Infections with Chryseomonas luteola (CDC group Ve-1) and flavimonas oryzihabitans (CDC group Ve-2)

We have described 15 cases of infection due to Chryseomonas luteola and Flavimonas oryzihabitans isolated between May 1990 and May 1994. These infections were often associated with the presence of a foreign body, especially central venous access and joint prosthesis. The high frequency of isolating...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Medicine (Baltimore) 1995-03, Vol.74 (2), p.83-88
Hauptverfasser: Rahav, G, Simhon, A, Mattan, Y, Moses, A E, Sacks, T
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 88
container_issue 2
container_start_page 83
container_title Medicine (Baltimore)
container_volume 74
creator Rahav, G
Simhon, A
Mattan, Y
Moses, A E
Sacks, T
description We have described 15 cases of infection due to Chryseomonas luteola and Flavimonas oryzihabitans isolated between May 1990 and May 1994. These infections were often associated with the presence of a foreign body, especially central venous access and joint prosthesis. The high frequency of isolating C. luteola and F. oryzihabitans probably expresses the awareness of the clinicians and the laboratory to the importance of these bacteria, especially in patients with the presence of a foreign material.
doi_str_mv 10.1097/00005792-199503000-00003
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_77180380</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>77180380</sourcerecordid><originalsourceid>FETCH-LOGICAL-c360t-6efbfc6ff07d4adf7a013f366352dfd0e318024d9e986438c75b725d8eaf45293</originalsourceid><addsrcrecordid>eNpVUMtOwzAQ9AFUSuETkHxC9BDwI47jIwpPqRIX4Go5sU2NkrjYCah8PS4tlVittNrRzOxqAIAYXWIk-BVKxbggGRaCIZq2bAPRAzBFiLCMC54fgeMY3xHClJN8Aia8FJjlxRQ0j701zeB8H-GXG5awWoZ1NL7zvYqwHQfjWwUvqpsKvgU_ruCryfAcql5D26pPt-X5sP52S1W7QSWf_2wyPwGHVrXRnO7mDLzc3T5XD9ni6f6xul5kDS3QkBXG1rYprEVc50pbrtK7lhYFZURbjQzFJSK5FkaURU7LhrOaE6ZLo2zOiKAzcL71XQX_MZo4yM7FxrSt6o0fo-Q8GdDUM1BuiU3wMQZj5Sq4ToW1xEhuMpV_mcp9pr8QTdKz3Y2x7ozeC3eB0h-qf3MD</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>77180380</pqid></control><display><type>article</type><title>Infections with Chryseomonas luteola (CDC group Ve-1) and flavimonas oryzihabitans (CDC group Ve-2)</title><source>MEDLINE</source><source>Journals@Ovid Complete</source><source>Wolters Kluwer Open Health</source><source>EZB-FREE-00999 freely available EZB journals</source><creator>Rahav, G ; Simhon, A ; Mattan, Y ; Moses, A E ; Sacks, T</creator><creatorcontrib>Rahav, G ; Simhon, A ; Mattan, Y ; Moses, A E ; Sacks, T</creatorcontrib><description>We have described 15 cases of infection due to Chryseomonas luteola and Flavimonas oryzihabitans isolated between May 1990 and May 1994. These infections were often associated with the presence of a foreign body, especially central venous access and joint prosthesis. The high frequency of isolating C. luteola and F. oryzihabitans probably expresses the awareness of the clinicians and the laboratory to the importance of these bacteria, especially in patients with the presence of a foreign material.</description><identifier>ISSN: 0025-7974</identifier><identifier>DOI: 10.1097/00005792-199503000-00003</identifier><identifier>PMID: 7891546</identifier><language>eng</language><publisher>United States</publisher><subject>Abscess - drug therapy ; Abscess - microbiology ; Adolescent ; Adult ; Aged ; Aged, 80 and over ; Anti-Bacterial Agents - therapeutic use ; Appendectomy - adverse effects ; Bone Diseases - drug therapy ; Bone Diseases - microbiology ; Cardiac Surgical Procedures - adverse effects ; Catheters, Indwelling - adverse effects ; Female ; Hip Joint - microbiology ; Hip Prosthesis - adverse effects ; Humans ; Joint Diseases - drug therapy ; Joint Diseases - microbiology ; Male ; Middle Aged ; Prosthesis-Related Infections - drug therapy ; Prosthesis-Related Infections - microbiology ; Pseudomonas - classification ; Pseudomonas - isolation &amp; purification ; Pseudomonas Infections - drug therapy ; Pseudomonas Infections - etiology ; Pseudomonas Infections - microbiology ; Surgical Wound Infection - drug therapy ; Surgical Wound Infection - microbiology</subject><ispartof>Medicine (Baltimore), 1995-03, Vol.74 (2), p.83-88</ispartof><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c360t-6efbfc6ff07d4adf7a013f366352dfd0e318024d9e986438c75b725d8eaf45293</citedby><cites>FETCH-LOGICAL-c360t-6efbfc6ff07d4adf7a013f366352dfd0e318024d9e986438c75b725d8eaf45293</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/7891546$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Rahav, G</creatorcontrib><creatorcontrib>Simhon, A</creatorcontrib><creatorcontrib>Mattan, Y</creatorcontrib><creatorcontrib>Moses, A E</creatorcontrib><creatorcontrib>Sacks, T</creatorcontrib><title>Infections with Chryseomonas luteola (CDC group Ve-1) and flavimonas oryzihabitans (CDC group Ve-2)</title><title>Medicine (Baltimore)</title><addtitle>Medicine (Baltimore)</addtitle><description>We have described 15 cases of infection due to Chryseomonas luteola and Flavimonas oryzihabitans isolated between May 1990 and May 1994. These infections were often associated with the presence of a foreign body, especially central venous access and joint prosthesis. The high frequency of isolating C. luteola and F. oryzihabitans probably expresses the awareness of the clinicians and the laboratory to the importance of these bacteria, especially in patients with the presence of a foreign material.</description><subject>Abscess - drug therapy</subject><subject>Abscess - microbiology</subject><subject>Adolescent</subject><subject>Adult</subject><subject>Aged</subject><subject>Aged, 80 and over</subject><subject>Anti-Bacterial Agents - therapeutic use</subject><subject>Appendectomy - adverse effects</subject><subject>Bone Diseases - drug therapy</subject><subject>Bone Diseases - microbiology</subject><subject>Cardiac Surgical Procedures - adverse effects</subject><subject>Catheters, Indwelling - adverse effects</subject><subject>Female</subject><subject>Hip Joint - microbiology</subject><subject>Hip Prosthesis - adverse effects</subject><subject>Humans</subject><subject>Joint Diseases - drug therapy</subject><subject>Joint Diseases - microbiology</subject><subject>Male</subject><subject>Middle Aged</subject><subject>Prosthesis-Related Infections - drug therapy</subject><subject>Prosthesis-Related Infections - microbiology</subject><subject>Pseudomonas - classification</subject><subject>Pseudomonas - isolation &amp; purification</subject><subject>Pseudomonas Infections - drug therapy</subject><subject>Pseudomonas Infections - etiology</subject><subject>Pseudomonas Infections - microbiology</subject><subject>Surgical Wound Infection - drug therapy</subject><subject>Surgical Wound Infection - microbiology</subject><issn>0025-7974</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1995</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpVUMtOwzAQ9AFUSuETkHxC9BDwI47jIwpPqRIX4Go5sU2NkrjYCah8PS4tlVittNrRzOxqAIAYXWIk-BVKxbggGRaCIZq2bAPRAzBFiLCMC54fgeMY3xHClJN8Aia8FJjlxRQ0j701zeB8H-GXG5awWoZ1NL7zvYqwHQfjWwUvqpsKvgU_ruCryfAcql5D26pPt-X5sP52S1W7QSWf_2wyPwGHVrXRnO7mDLzc3T5XD9ni6f6xul5kDS3QkBXG1rYprEVc50pbrtK7lhYFZURbjQzFJSK5FkaURU7LhrOaE6ZLo2zOiKAzcL71XQX_MZo4yM7FxrSt6o0fo-Q8GdDUM1BuiU3wMQZj5Sq4ToW1xEhuMpV_mcp9pr8QTdKz3Y2x7ozeC3eB0h-qf3MD</recordid><startdate>19950301</startdate><enddate>19950301</enddate><creator>Rahav, G</creator><creator>Simhon, A</creator><creator>Mattan, Y</creator><creator>Moses, A E</creator><creator>Sacks, T</creator><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>19950301</creationdate><title>Infections with Chryseomonas luteola (CDC group Ve-1) and flavimonas oryzihabitans (CDC group Ve-2)</title><author>Rahav, G ; Simhon, A ; Mattan, Y ; Moses, A E ; Sacks, T</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c360t-6efbfc6ff07d4adf7a013f366352dfd0e318024d9e986438c75b725d8eaf45293</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1995</creationdate><topic>Abscess - drug therapy</topic><topic>Abscess - microbiology</topic><topic>Adolescent</topic><topic>Adult</topic><topic>Aged</topic><topic>Aged, 80 and over</topic><topic>Anti-Bacterial Agents - therapeutic use</topic><topic>Appendectomy - adverse effects</topic><topic>Bone Diseases - drug therapy</topic><topic>Bone Diseases - microbiology</topic><topic>Cardiac Surgical Procedures - adverse effects</topic><topic>Catheters, Indwelling - adverse effects</topic><topic>Female</topic><topic>Hip Joint - microbiology</topic><topic>Hip Prosthesis - adverse effects</topic><topic>Humans</topic><topic>Joint Diseases - drug therapy</topic><topic>Joint Diseases - microbiology</topic><topic>Male</topic><topic>Middle Aged</topic><topic>Prosthesis-Related Infections - drug therapy</topic><topic>Prosthesis-Related Infections - microbiology</topic><topic>Pseudomonas - classification</topic><topic>Pseudomonas - isolation &amp; purification</topic><topic>Pseudomonas Infections - drug therapy</topic><topic>Pseudomonas Infections - etiology</topic><topic>Pseudomonas Infections - microbiology</topic><topic>Surgical Wound Infection - drug therapy</topic><topic>Surgical Wound Infection - microbiology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Rahav, G</creatorcontrib><creatorcontrib>Simhon, A</creatorcontrib><creatorcontrib>Mattan, Y</creatorcontrib><creatorcontrib>Moses, A E</creatorcontrib><creatorcontrib>Sacks, T</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Medicine (Baltimore)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Rahav, G</au><au>Simhon, A</au><au>Mattan, Y</au><au>Moses, A E</au><au>Sacks, T</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Infections with Chryseomonas luteola (CDC group Ve-1) and flavimonas oryzihabitans (CDC group Ve-2)</atitle><jtitle>Medicine (Baltimore)</jtitle><addtitle>Medicine (Baltimore)</addtitle><date>1995-03-01</date><risdate>1995</risdate><volume>74</volume><issue>2</issue><spage>83</spage><epage>88</epage><pages>83-88</pages><issn>0025-7974</issn><abstract>We have described 15 cases of infection due to Chryseomonas luteola and Flavimonas oryzihabitans isolated between May 1990 and May 1994. These infections were often associated with the presence of a foreign body, especially central venous access and joint prosthesis. The high frequency of isolating C. luteola and F. oryzihabitans probably expresses the awareness of the clinicians and the laboratory to the importance of these bacteria, especially in patients with the presence of a foreign material.</abstract><cop>United States</cop><pmid>7891546</pmid><doi>10.1097/00005792-199503000-00003</doi><tpages>6</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0025-7974
ispartof Medicine (Baltimore), 1995-03, Vol.74 (2), p.83-88
issn 0025-7974
language eng
recordid cdi_proquest_miscellaneous_77180380
source MEDLINE; Journals@Ovid Complete; Wolters Kluwer Open Health; EZB-FREE-00999 freely available EZB journals
subjects Abscess - drug therapy
Abscess - microbiology
Adolescent
Adult
Aged
Aged, 80 and over
Anti-Bacterial Agents - therapeutic use
Appendectomy - adverse effects
Bone Diseases - drug therapy
Bone Diseases - microbiology
Cardiac Surgical Procedures - adverse effects
Catheters, Indwelling - adverse effects
Female
Hip Joint - microbiology
Hip Prosthesis - adverse effects
Humans
Joint Diseases - drug therapy
Joint Diseases - microbiology
Male
Middle Aged
Prosthesis-Related Infections - drug therapy
Prosthesis-Related Infections - microbiology
Pseudomonas - classification
Pseudomonas - isolation & purification
Pseudomonas Infections - drug therapy
Pseudomonas Infections - etiology
Pseudomonas Infections - microbiology
Surgical Wound Infection - drug therapy
Surgical Wound Infection - microbiology
title Infections with Chryseomonas luteola (CDC group Ve-1) and flavimonas oryzihabitans (CDC group Ve-2)
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-03T06%3A25%3A33IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Infections%20with%20Chryseomonas%20luteola%20(CDC%20group%20Ve-1)%20and%20flavimonas%20oryzihabitans%20(CDC%20group%20Ve-2)&rft.jtitle=Medicine%20(Baltimore)&rft.au=Rahav,%20G&rft.date=1995-03-01&rft.volume=74&rft.issue=2&rft.spage=83&rft.epage=88&rft.pages=83-88&rft.issn=0025-7974&rft_id=info:doi/10.1097/00005792-199503000-00003&rft_dat=%3Cproquest_cross%3E77180380%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=77180380&rft_id=info:pmid/7891546&rfr_iscdi=true